MAPK3 and COVID-19: We sought to test the hypothesis that the S1 spike protein is sufficient to promote inflammation, including activation of MAPK (ERK1/2) and/or NF-kB signaling and production of inflammatory cytokines, as a potential mechanism contributing to inflammation in COVID-19 and PASC [15,18,19,31].